Change the experience of health!

About G4A

Bayer G4A is a global program that offers support to startups and companies that are developing innovative solutions in health and care. We do it by providing: places to work, mentors and experts to guide companies with business development, financial support, and networking opportunities through our extensive networks.

More about G4A
  • Mentoring & coaching
  • Financial support
  • Office space
  • Networking

Who we are looking to collaborate with

G4A invites you to submit your innovative digital health products or solutions that can be applied around specific challenges to improve self-care, health outcomes, or improve processes along the value chain. All decisions will be made at Bayer’s sole discretion.

More about programs
  • Remote Monitoring, Sensors
  • Wearables
  • Big Data
  • Digital Assistants, Robots
  • Artificial Intelligence
  • Augmented Reality
  • Personal Genomics Software
  • Games for Health

G4A programs are running in 13 countries on a local and global scale. We are looking to find the best health tech talent around and help you grow in various ways.

More about programs

Success stories

Startups from our accelerator programs are changing the game in digital health. Read more about them below:


Artificial Intelligence, Prediction
  • Program Accelerator Berlin 2016
  • Country Germany

Our algorithm detects micro-movements through the sensors built into smartphones and wearables and translates them into daily activities that have an impact on your condition. By taking into account these digital biomarkers, it is possible to put symptoms into context and predict their occurrence before it is too late.

Sebastian Sujka, CEO


Clinical Trials, Platform
  • Program Accelerator Berlin 2015
  • Country Germany

Our Bayer mentors provided us with unique insights into the pharmaceutical industrys needs concerning our clinical trials solution that we could not have gained on our own.

Alexander Puschilov, Viomedo CEO
  • 18programs

  • 82startups

  • €260m+euros invested